Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration, Biofuel, Renewable Energy, Food & Agriculture, Bioremediation) – Global Forecast to 2025

2020-02-07
Price :
Published : Feb-2020
No. of Pages : 256

“The synthetic biology market is projected to grow at a CAGR of 23.9% during the forecast period (2020–2025).”

The synthetic biology market is projected to reach USD 19.8 billion by 2025 from USD 6.8 billion in 2020, at a CAGR of 23.9%.Factors such as the increasing demand for synthetic genes and synthetic cells, wide range of applications of synthetic biology, declining cost of DNA sequencing and synthesizing, increasing R&D funding and initiatives in synthetic biology, and increasing investments in the market are propelling the growth of this market. However, rising biosafety, biosecurity, and ethical concerns related to synthetic biology is likely to hamper the growth of this market.

“The oligonucleotides and synthetic DNA segment is expected to grow at the highest rate during the forecast period.”

Based on tools, the market has been segmented into oligonucleotides and synthetic DNA, enzymes, cloning technology kits, chassis organisms, xeno-nucleic acids, and synthetic cells. In 2019, the oligonucleotides and synthetic DNA segment is expected to register the highest CAGR during the forecast period. This can be attributed to factors such as the rising demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of applications, such as pharmaceuticals, nutraceuticals, personal care, flavors and fragrances, probiotics, green chemicals, and industrial enzymes.

The genome engineering segment is expected to grow at the highest CAGR during the forecast period.”

On the basis of technology, the market is segmented into gene synthesis, genome engineering, cloning, sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, nanotechnology, bioinformatics technologies.

The genome engineering segment is expected to register the highest CAGR during the forecast period due to factors such as the increasing use of engineering technologies for manipulating complex genomes, growing therapeutics development for cancer and other diseases, and the increasing technological advances in CRISPR-toolbox and DNA synthesis technologies.

“The industrial applications segment is expected to grow at the highest CAGR during the forecast period.”

Based on application, the synthetic biology market is segmented into medical, industrial, food & agricultural, and environmental applications. The industrial applications segment is expected to grow at the highest CAGR owing to the rising applications of synthetic biology in producing renewable energy, biomaterials & green chemicals, and enzymes.

“The Asia Pacific is projected to witness the highest growth during the forecast period.”

The synthetic biology market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the synthetic biology market. However, the APAC region is expected to witness the highest growth during the forecast period owing to the growth in the number of pharmaceutical & biopharmaceutical companies, the increasing number of healthcare & life science facilities, and increasing requirements for regulatory compliance in pharmaceutical and biopharmaceutical companies, growing number of international alliances, heavy funding for synthetic biology research, and strong government support. Furthermore, the increasing focus on the Asia Pacific markets due to their low-cost manufacturing advantage also provides growth opportunities for manufacturers.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20%
  • By Designation: C-level–35%, Director-level–45%, and Others–20%
  • By Region: North America–45%, Europe–30%, Asia Pacific–20%,Latin America–3%, and the Middle East & Africa–2%

The prominent players in the synthetic biology market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris, Inc. (US), Intrexon Corporation (US), GenScript Biotech Corporation (China), Twist Bioscience (US), Synthetic Genomics, Inc. (US), Codexis, Inc. (US), Synthego Corporation (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg), Cyrus Biotechnology Inc. (US), ATUM (US), TeselaGen (US), Arzeda (US), Integrated DNA Technologies, Inc. (US), and New England Biolabs (US).

Research Coverage:

The report analyzes the market for various synthetic biology market and their adoption patterns. It aims at estimating the market size and future growth potential of the synthetic biology market and its sub segments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the synthetic biology market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the synthetic biology market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the synthetic biology market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Filed in: Biotechnology
Publisher : marketsandmarkets
More Reports
Title Price Buy Now

Glycomics / Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (Mass Spectrometry, Chromatography), Carbohydrates, Reagents & Chemicals), Application (Disease Diagnostics), End-User (Academic) -Global Forecasts to 2025

“Increasing R&D investments in pharmaceutical companies is a major factor driving the growth of the glycomics market.” The global glycomics market is projected to reach USD 2.0 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 13.8% during the forecast period. The growth of this market is majorly driven by the increasing R&D expenditure and funding for proteomics and glycomics research, growth of the proteomics market, and technological advancements in glycomics instrumentation. However, the high cost of tools is expected to be the major challenge for the growth of the global glycomics market during the forecast period. “Academic research institutes segment accounted for the largest share of the glycomics market, by end-user, in 2019.” Based on end-user, t......
$5650

Top Trends in the Agricultural Biologicals Market by Agricultural Biologicals, Biocontrols, Biofungicides, Bioinsecticides, Bionematicides, Biostimulants, Biofertilizers, Agricultural Inoculants, Agricultural Pheromones, Biological Seed Treatment – Global Forecast to 2025

“The agricultural biological market is projected to grow at a CAGR of 13.7% during the forecast period.” The agricultural biologicals market is projected to grow at a CAGR of 13.7% from an estimated value of USD 9.9 billion in 2020 to reach USD 18.9 billion by 2025.Agricultural biologicals market has been gaining wide importance among farmers to produce chemical-free food products with the adoption of natural methods. The increased public awareness of the benefits of integrated pest management has created an understanding of plant defense mechanisms among farmers. The increasing trend of organic farming, biotic & a biotic factors affecting plant growth, favorable government regulations, hazards of using chemicals on the living organisms and the environment are the major driving ......
$5650

Neuromodulation Market by Technology- Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation), Application (Ischemia, Chronic Pain, Parkinson’s, Depression, Tremor, Epilepsy, Migraine) – Global Forecast to 2025

“The neuromodulation market is projected to grow at a CAGR of 8.6% during the forecast period (2020–2025).” The global neuromodulation market size is projected to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020, at a CAGR of 8.6%. The growth of this market is driven majorly by factors such as the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on neurodegenerative disorders. However, the high cost of neuromodulation procedures and equipment, along with the dearth of a trained workforce, will challenge market growth. “By technology, the internal neuromodulation segment is expected to grow at the highest CAGR during the forecast period.” Based on technology, the neuromodulation ma......
$5650

Agricultural Biologicals Market by Function (Biocontrol, Biofertilizers, Biostimulants), Product Type (Microbials, Macrobials, Semiochemicals, Natural), Mode of Application (Foliar spray, Soil and Seed treatment), Crop Type, and Region – Global Forecast to 2025

The agricultural biologicals market is projected to grow at a CAGR of 13.6% from 2019 to 2025. The agricultural biologicals market size is estimated to account for a value of USD 8.8 billion in 2019 and is projected to grow at a CAGR of 13.6% to reach a value of USD 18.9 billion by 2025. The demand for agricultural biologicals is increasing due to the growing trend of sustainable agriculture and the rising demand for organic food products worldwide. The registration of these products is one of the major restrains that is projected to hinder the growth of this market. Strict government regulations and less guidance discourage the companies to get their bioproducts registered, which inhibits the commercialization of new products The biocontrol segment, by function, is projected to be t......
$5650

Sterile Filtration Market by Product (Cartridge, Capsule, Syringe), Application (Fill Finish Process, Bioburden Reduction), Membrane (Nylon, PTFE, PES, PVDF), Pore Size (0.2 Microns), End User (Pharmaceutical, Biotechnology, F&B) – Global Forecast to 2025

“Advantages of sterile filtration over non-sterile filtration are a major factor expected to drive the overall growth of the sterile filtration market.” The global sterile filtration market is projected to grow from USD 4.7 billion in 2019 to USD 7.4 billion by 2025, at a CAGR of 8.0% from 2019 to 2025. The major factors driving the growth of this market include the advantages of sterile filters over non-sterile filters, the growing demand for pure water in end-use industries, increasing adoption of single-use devices & disposables, and the rising focus on the development of large-molecule biopharmaceutical drugs. However, the high price sensitivity among end users is a major challenge for the growth of this market. “The capsule filter segment is expected to grow at the hig......
$5650

Drug Discovery Services Market by Process (Target Selection, Validation, Lead Optimization), Type (Medicinal Chemistry, DMPK), Drug Type (Biologics, Small Molecules), Therapeutic (Oncology, Neurology), Company (Tier 1, 2, 3) – Global Forecast to 2025

“Drug discovery services market to register a CAGR of 12.1% from 2020 to 2025.” The global drug discovery services market is projected to reach USD 19.1 billion by 2025 from USD 10.7 billion in 2020, at a CAGR of 12.1% from 2020 to 2025. The growth of the industry is driven primarily by factors such as growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing demand for outsourcing analytical testing and clinical trial services, initiatives for research on rare diseases and orphan drugs, and focus on drug discovery. Growth in the biologics market and patent expiries will further provide opportunities in the drug discovery services industry. Developing economies are expected to offer a wide range of growth opportunities for players in the market. ......
$5650

Marfan Syndrome Global Clinical Trials Review, H1, 2020

Marfan Syndrome Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, "Marfan Syndrome Global Clinical Trials Review, H1, 2020" provides an overview of Marfan Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Marfan Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. ......
$2500

Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, shingles, Rabies), Route (IM, SC, ID, Oral), Patient (Pediatric, Adult), Type – Global Forecast to 2024

“The vaccines market is projected to grow at a CAGR of 7.0% during the forecast period (2019–2024).” The global vaccines market is projected to reach USD 58.4 billion by 2024 from USD 41.7 billion in 2019, at a CAGR of 7.0%during the forecast period. The key factors driving the growth of this market include the high prevalence of infectious diseases, growing support for vaccine R&D, investments in vaccine development, and rising focus on immunization. However, the huge capital investments required for developing vaccines may restrain market growth. “The pneumococcal disease segment will continue to dominate the vaccines market during the forecast period.” On the basis of disease indication, the vaccines market is segmented into pneumococcal disease, influenza, DTP, h......
$5650

Animal Growth Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics), Animal (Poultry, Porcine, Livestock, Aquaculture) – Global Forecast to 2024

“The animal growth promoters and performance enhancers market projected to grow at a CAGR of 5.9% during the forecast period (2019–2024).” The global animal growth promoters and performance enhancers market is projected to reach USD 18.5 billion by 2024 from an estimated USD 13.9 billion in 2019, at a CAGR of 5.9%during the forecast period. The key factors driving the growth of this market is the increasing global meat demand, research into alternatives to antibiotics, and the need to deal with epidemics and environmental factors. However, various countries have stringent regulations in place against antibiotics and particular growth promoters, which has affected their adoption. “By type, the non-antibiotic growth promoters segment is expected to grow at the highest CAGR duri......
$5650

Gene Therapy Market by Vectors [Non-viral (Oligonucleotides), Viral (Retroviral (Gammaretroviral, Lentiviral)), Adeno-associated], Indication (Cancer, Neurological Diseases), Delivery Method (In Vivo, Ex Vivo), Region – Global Forecast to 2024

“High incidence of cancer& other target diseases is a major factor driving the growth of the gene therapy market” The global gene therapy market is projected to reach USD 13.0 billion by 2024 from USD 3.8 billion in 2019, at a CAGR of 27.8% during the forecast period. The high incidence of cancer and other target diseases, availability of reimbursement, and the launch of new products are the major factors driving the growth of this market. In addition, the strong product pipeline of market players is expected to offer significant growth opportunities in the coming years. However, the high cost of treatment is expected to hamper market growth to a certain extent in the coming years. “Neurological diseases segment accounted for the largest share of the gene therapy market, by......
$5650
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy